医学伦理研究助手
前沿
论文精读

论文 · 综述

微流控集成CRISPR-Cas生物传感器用于海洋污染物与病原监测:综述

Biosensors (Basel) · 2026年9月1日 · Ali 等 5 位作者

问这篇
一分钟了解要点综述微流控与CRISPR-Cas检测结合用于海洋重金属、生物毒素、病原和耐药基因现场监测。结果CRISPR-Cas诊断技术借助Cas12a/Cas13a的可编程反式切割实现阿摩尔级灵敏度,与提供自动化和微型化的微流控平台结合后有望用于现场部署。

不需要生物学背景,多打比方

正在获取全文并生成讲解(拿不到全文就依据摘要)…

已等待 0 秒大约需要 10–20 秒

可以先看别的,做好了会自动出现在这里。

这篇还没有动画

动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要一两分钟。

目前只拿到了摘要全文暂时拿不到(可能不是免费全文)。下面是论文摘要。

摘要Abstract

摘要第 1 段问这一段

Marine ecosystems face escalating threats from heavy metals, harmful algal bloom toxins, pathogens, and antibiotic resistance genes, yet conventional detection methods remain laboratory-dependent and incapable of real-time, multiplexed field monitoring. CRISPR-Cas diagnostics, leveraging programmable Cas12a/Cas13a trans-cleavage for attomolar-level sensitivity, offers a transformative solution when integrated with microfluidic platforms that provide the automation and miniaturisation required for field deployment. This review systematically examines this emerging convergence across four marine target classes: heavy metals, biotoxins, pathogens, and resistance genes alongside integration architectures, signal readout strategies, and comparative performance benchmarking. We identify that only a small fraction of reported platforms have been validated in authentic seawater, with cross-class multiplexing, biofouling resistance during autonomous deployment, and regulatory standardisation remaining largely unaddressed. By synthesising this rapidly developing literature and articulating these unresolved challenges, this review provides a foundational reference and research agenda for translating microfluidic-CRISPR biosensors from laboratory proof-of-concept to operational marine environmental surveillance.

这篇对您:
讲解或动画有问题: